Showing results (391-400 of 5,925) with videos related to

Sort By:
Pageof 593
The Prostate|August 10, 1999
Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell lineJ B Virgin, P M Hurley, F A Nahhas, et al.
The Prostate|May 20, 1999
Artificial neural network analysis (ANNA) of prostatic transrectal ultrasoundT Loch, I Leuschner, C Genberg, et al.
The Prostate|October 12, 1999
Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapyV S Khoo, A Pollack, D Cowen, et al.
The Prostate|July 9, 1999
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaPP Sundareshan, R B Nagle, G T Bowden
The Prostate|July 9, 1999
Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistanceP A Davol, A R Frackelton
The Prostate|November 2, 1999
Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptorB Planz, H T Aretz, Q Wang, et al.
The Prostate|November 2, 1999
Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude miceX S Wan, J H Ware, L Zhang, et al.
The Prostate|November 2, 1999
Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growthK Mitsumori, A Terai, H Oka, et al.
The Prostate|January 5, 2000
Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?F H Schröder, R Kranse, N Barbet, et al.
The Prostate|January 5, 2000
Neuroendocrine cells during human prostate development: does neuroendocrine cell density remain constant during fetal as well as postnatal life?Y Xue, J van der Laak, F Smedts, et al.
Pageof 593